首页 | 本学科首页   官方微博 | 高级检索  
检索        

新诊断2型糖尿病患者两种短期胰岛素强化治疗的疗效比较
引用本文:冯尤健,陈祥彪,刘桑燕,巫晓强,刘碧玲.新诊断2型糖尿病患者两种短期胰岛素强化治疗的疗效比较[J].中华糖尿病杂志,2008,16(1):40-41.
作者姓名:冯尤健  陈祥彪  刘桑燕  巫晓强  刘碧玲
作者单位:福建省三明市第二医院,366000
摘    要:新诊断2型糖尿病(T2DM)患者72例随机分为短期持续性皮下胰岛素泵(CSII)组及多次胰岛素皮下注射(MSII)组。结果提示短期CSII及MSII治疗均可改善新诊断T2DM患者胰岛β细胞功能、减轻胰岛素抵抗;CSII较MSII效果好。其疗效与病程长短、治疗前血糖、胰岛素、C肽水平以及医师的技能有关。

关 键 词:糖尿病  2型  胰岛素强化治疗  胰岛β细胞
收稿时间:2006-02-27
修稿时间:2006年2月27日

Comparison of therapeutic effects between two kinds of short-term intensive insulin treatments in newly diagnosed type 2 diabetic patients
FENG You-jian,CHEN Xiang-biao,LIU San-yan,et al..Comparison of therapeutic effects between two kinds of short-term intensive insulin treatments in newly diagnosed type 2 diabetic patients[J].CHINESE JOURNAL OF DIABETES MELLITUS,2008,16(1):40-41.
Authors:FENG You-jian  CHEN Xiang-biao  LIU San-yan  
Institution:FENG You-jian,CHEN Xiang-biao,LIU San-yan,et al.The Second Hospital of Sanming,Fujian Province.Yong\'an 366000,China
Abstract:72 newly diagnosed type 2 diabetic patients were randomly divided into continuous subcutaneous insulin infusion(CSII) group and multiple subcutaneous insulin injection (MSII) group. The results showed that the short-term treatment of CSII and MSII could improve the β-cell function and lessen the insulin resistance in newly diagnosed type 2 diabetic patients, and CSII might be more effective. The effect was correlated to the course, levels of blood glucose,insulin, and C-peptide before treatment.
Keywords:Diabetes mellitus  type 2  Intensive insulin therapy  Pancreatic beta cell
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号